NASDAQ:SPNC - Spectranetics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$38.45Today's Range$38.45 - $38.4552-Week Range$19.80 - $38.55VolumeN/AAverage Volume788,356 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads. Its geographic segments are U.S. Medical and International Medical. Its product offerings in U.S. Medical segment include medical devices used in minimally invasive procedures within the cardiovascular system, including fiber-optic devices and non-fiber-optic products (disposables), an excimer laser system (equipment) and the service of the excimer laser system (service). Its products are used in multiple vascular procedures, including peripheral atherectomy, crossing arterial blockages, coronary atherectomy and thrombectomy. Its International Medical segment is primarily engaged in distribution activities. Receive SPNC News and Ratings via Email Sign-up to receive the latest news and ratings for SPNC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Supplies SectorN/A Current SymbolNASDAQ:SPNC Previous Symbol CUSIP84760C10 CIK789132 Webwww.spectranetics.com Phone+1-719-6338333Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Spectranetics (NASDAQ:SPNC) Frequently Asked Questions What is Spectranetics' stock symbol? Spectranetics trades on the NASDAQ under the ticker symbol "SPNC." How were Spectranetics' earnings last quarter? Spectranetics Corp (NASDAQ:SPNC) posted its earnings results on Thursday, August, 3rd. The medical equipment provider reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.27) by $0.29. The medical equipment provider earned $74.71 million during the quarter, compared to analysts' expectations of $73.82 million. The company's revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company earned ($0.35) EPS. View Spectranetics' Earnings History. Has Spectranetics been receiving favorable news coverage? Media coverage about SPNC stock has been trending neutral on Tuesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Spectranetics earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the next several days. Who are Spectranetics' key executives? Spectranetics' management team includes the folowing people: B. Kristine Johnson, Chairman of the Board (Age 65)Scott William Drake, President, Chief Executive Officer, Director (Age 49)Stacy McMahan, Chief Financial Officer (Age 53)Shahriar Matin, Chief Operating Officer (Age 42)Scott Hutton, Senior Vice President and General Manager of Vascular Intervention (Age 45)Donna Ford-Serbu, Senior Vice President - Sales and Marketing of Lead Management (Age 48)William C. Jennings, Independent Director (Age 78)Daniel A. Pelak, Independent Director (Age 65)Joseph M. Ruggio M.D., Independent Director (Age 62)Maria Degois Sainz, Independent Director (Age 51) How do I buy shares of Spectranetics? Shares of SPNC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Spectranetics' official website? The official website for Spectranetics is http://www.spectranetics.com. How can I contact Spectranetics? Spectranetics' mailing address is 9965 Federal Dr, COLORADO SPRINGS, CO 80921-3822, United States. The medical equipment provider can be reached via phone at +1-719-6338333. MarketBeat Community Rating for Spectranetics (NASDAQ SPNC)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 358 (Vote Outperform)Underperform Votes: 250 (Vote Underperform)Total Votes: 608MarketBeat's community ratings are surveys of what our community members think about Spectranetics and other stocks. Vote "Outperform" if you believe SPNC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SPNC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/19/2019 by MarketBeat.com StaffFeatured Article: What is a capital gain?